Pieter Jan Poortmans MD, Maria Eva Argenziano MD, Michele Montori MD, Andrea Sorge MD, Lynn Debels MD, Lobke Desomer MD, David James Tate MBBS, MA (Cantab), PhD
{"title":"Knife-assisted endoscopic full-thickness resection of deeply invasive esophageal adenocarcinoma: a case series","authors":"Pieter Jan Poortmans MD, Maria Eva Argenziano MD, Michele Montori MD, Andrea Sorge MD, Lynn Debels MD, Lobke Desomer MD, David James Tate MBBS, MA (Cantab), PhD","doi":"10.1016/j.igie.2025.12.008","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Esophageal adenocarcinoma (EAC) incidence is rising globally, and current therapeutic options carry substantial morbidity and mortality. We report the feasibility and early outcomes of knife-assisted endoscopic full-thickness resection (kFTR) as a palliative local control in nonsurgical candidates.</div></div><div><h3>Methods</h3><div>Three patients with suspected locally advanced distal EAC (clinical tumor stage T1b-T2), no nodal or distant disease, and high Charlson Comorbidity Index scores were unfit for surgery and declined chemoradiotherapy. All consented to kFTR: a submucosal pocket was created cranial to the suspected invasive area, the muscle-retracting sign was identified, and the muscularis propria was incised to access the periesophageal space. The lesion was dissected laterally and resected en bloc. A fully covered metal stent was then placed.</div></div><div><h3>Results</h3><div>Patients resumed oral intake on day 5 without major adverse events. All had EAC pathologic tumor stage 1b with invasion into the deepest layer of the submucosa; 2 had positive vertical margins. One remained disease-free (24 months); 2 had local recurrence by 6 months but remained asymptomatic at last follow-up (10 and 14 months).</div></div><div><h3>Conclusions</h3><div>In carefully selected symptomatic, inoperable patients, kFTR achieved short-to-medium term symptom control for locally advanced EAC with acceptable safety.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"5 3","pages":"Pages 433-439"},"PeriodicalIF":0.0000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iGIE","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949708625001864","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/26 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Aims
Esophageal adenocarcinoma (EAC) incidence is rising globally, and current therapeutic options carry substantial morbidity and mortality. We report the feasibility and early outcomes of knife-assisted endoscopic full-thickness resection (kFTR) as a palliative local control in nonsurgical candidates.
Methods
Three patients with suspected locally advanced distal EAC (clinical tumor stage T1b-T2), no nodal or distant disease, and high Charlson Comorbidity Index scores were unfit for surgery and declined chemoradiotherapy. All consented to kFTR: a submucosal pocket was created cranial to the suspected invasive area, the muscle-retracting sign was identified, and the muscularis propria was incised to access the periesophageal space. The lesion was dissected laterally and resected en bloc. A fully covered metal stent was then placed.
Results
Patients resumed oral intake on day 5 without major adverse events. All had EAC pathologic tumor stage 1b with invasion into the deepest layer of the submucosa; 2 had positive vertical margins. One remained disease-free (24 months); 2 had local recurrence by 6 months but remained asymptomatic at last follow-up (10 and 14 months).
Conclusions
In carefully selected symptomatic, inoperable patients, kFTR achieved short-to-medium term symptom control for locally advanced EAC with acceptable safety.